Voluntary Recall of two batches of Dopram100 MG /5ML produced by EUMEDICA PHARMACEUTIC ALS FRANCE Manufacturer
2026-02-12
الاسم التجاري الاسم العلمي رقم التسجيل رقم التشغيلة المتأثرة الشركة الصانعة Trade Name Scientific Name Register Number Affected batch number Manufacturer Dopram 100 MG /5ML DOXAPRAM غير مسجل 50478 50293 EUMEDICA PHARMACEUTIC ALS FRANCE
التصنيف
ملف
التاريخ
2025-11-02
اسم المستحضر
Dopram 100 MG /5ML
اجراء الاستدعاء
مستوى الاستدعاء
نوع المستحضر
سبب السحب
SFDA has issued a recall of two batches of Dopram 100 MG /5ML due to non-compliance with specifications. The company requested voluntary recall of the affected batches.
التوصيات
For healthcare professionals: Stop dispensing the affected batches immediately. Embargo/Quarantine all remaining stock. Affected batches should be returned to the supplier.
For patients,
- Consult your healthcare provider prior to discontinuing use of the affected batches, or for any health concerns.
- Contact the recalling firm or SFDA if you have any questions about the recall.
- Adverse reactions or quality problems experienced with the use of this product may be reported to Saudi Vigilance either online or call center (Call 19999).
评论与建议
如对政府服务有任何咨询或意见,请填写所需信息。